A randomized, open-label study of the efficacy of trimetazidine in preventing acute myocardial injury in patients hospitalized for moderate to severe acute respiratory syndrome caused by SARS-CoV-2
31 August 2025 (08:15 - 09:00)
Organised by: 
About the speaker
Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)
3 More presentations in this session
Mr A. Hashemi (Tehran, IR)
Pulse wave velocity progression determinants: no significant association with novel lipid parameters
Doctor M. Bellomare (Milan, IT)
Associate Professor I. Shehata (Zagazig, EG)
Access the full session
The Event
ESC Congress 2025
31 August 2025
08:15 CET
